These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 10506720

  • 21. Radiosensitisation in normal tissues with oxygen, carbogen or nicotinamide: therapeutic gain comparisons for fractionated x-ray schedules.
    Rojas A, Vojnovic B, Johns H, Joiner MC, Martindale C, Fowler JF, Denekamp J.
    Radiother Oncol; 1996 Apr; 39(1):53-64. PubMed ID: 8735494
    [Abstract] [Full Text] [Related]

  • 22. A phase III randomized study of misonidazole plus radiation vs. radiation alone for cervix cancer.
    Chan P, Milosevic M, Fyles A, Carson J, Pintilie M, Rauth M, Thomas G.
    Radiother Oncol; 2004 Mar; 70(3):295-9. PubMed ID: 15064016
    [Abstract] [Full Text] [Related]

  • 23. ARCON: accelerated radiotherapy with carbogen and nicotinamide in non small cell lung cancer: a phase I/II study by the EORTC.
    Bernier J, Denekamp J, Rojas A, Trovò M, Horiot JC, Hamers H, Antognoni P, Dahl O, Richaud P, Kaanders J, van Glabbeke M, Piérart M.
    Radiother Oncol; 1999 Aug; 52(2):149-56. PubMed ID: 10577700
    [Abstract] [Full Text] [Related]

  • 24. Human tumor blood flow is enhanced by nicotinamide and carbogen breathing.
    Powell ME, Hill SA, Saunders MI, Hoskin PJ, Chaplin DJ.
    Cancer Res; 1997 Dec 01; 57(23):5261-4. PubMed ID: 9393746
    [Abstract] [Full Text] [Related]

  • 25. Accelerated radiotherapy, carbogen, and nicotinamide in glioblastoma multiforme: report of European Organization for Research and Treatment of Cancer trial 22933.
    Miralbell R, Mornex F, Greiner R, Bolla M, Storme G, Hulshof M, Bernier J, Denekamp J, Rojas AM, Pierart M, van Glabbeke M, Mirimanoff RO.
    J Clin Oncol; 1999 Oct 01; 17(10):3143-9. PubMed ID: 10506611
    [Abstract] [Full Text] [Related]

  • 26. Radiotherapy with carbogen breathing and nicotinamide in head and neck cancer: feasibility and toxicity.
    Kaanders JH, Pop LA, Marres HA, van der Maazen RW, van der Kogel AJ, van Daal WA.
    Radiother Oncol; 1995 Dec 01; 37(3):190-8. PubMed ID: 8746587
    [Abstract] [Full Text] [Related]

  • 27. A randomised trial of accelerated radiotherapy for localised invasive bladder cancer.
    Horwich A, Dearnaley D, Huddart R, Graham J, Bessell E, Mason M, Bliss J.
    Radiother Oncol; 2005 Apr 01; 75(1):34-43. PubMed ID: 15878099
    [Abstract] [Full Text] [Related]

  • 28. Carbogen inhalation in cervical cancer: assessment of oxygenation change.
    Aquino-Parsons C, Lim P, Green A, Minchinton AI.
    Gynecol Oncol; 1999 Aug 01; 74(2):259-64. PubMed ID: 10419742
    [Abstract] [Full Text] [Related]

  • 29. Accelerated radiotherapy with carbogen and nicotinamide for laryngeal cancer: results of a phase III randomized trial.
    Janssens GO, Rademakers SE, Terhaard CH, Doornaert PA, Bijl HP, van den Ende P, Chin A, Marres HA, de Bree R, van der Kogel AJ, Hoogsteen IJ, Bussink J, Span PN, Kaanders JH.
    J Clin Oncol; 2012 May 20; 30(15):1777-83. PubMed ID: 22508814
    [Abstract] [Full Text] [Related]

  • 30. Is hyperbaric oxygen more effective than carbogen/nicotinamide in tumor radiation response?
    Hartmann KA, Van der Kleij AJ, Schneider CJ, Sminia P.
    Radiat Res; 1997 Nov 20; 148(5):523-5. PubMed ID: 9355875
    [No Abstract] [Full Text] [Related]

  • 31. Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy.
    Cowan RA, McBain CA, Ryder WD, Wylie JP, Logue JP, Turner SL, Van der Voet J, Collins CD, Khoo VS, Read GR.
    Int J Radiat Oncol Biol Phys; 2004 May 01; 59(1):197-207. PubMed ID: 15093917
    [Abstract] [Full Text] [Related]

  • 32. Long-term outcome of radiation-based conservation therapy for invasive bladder cancer.
    Chung PW, Bristow RG, Milosevic MF, Yi QL, Jewett MA, Warde PR, Catton CN, McLean M, Moore M, Tannock IF, Gospodarowicz MK.
    Urol Oncol; 2007 May 01; 25(4):303-9. PubMed ID: 17628296
    [Abstract] [Full Text] [Related]

  • 33. Hypoxic tumor cell radiosensitization: role of the iNOS/NO pathway.
    De Ridder M, Van Esch G, Engels B, Verovski V, Storme G.
    Bull Cancer; 2008 Mar 01; 95(3):282-91. PubMed ID: 18390408
    [Abstract] [Full Text] [Related]

  • 34. Accelerated radiotherapy, carbogen and nicotinamide (ARCON) in locally advanced head and neck cancer: a feasibility study.
    Saunders MI, Hoskin PJ, Pigott K, Powell ME, Goodchild K, Dische S, Denekamp J, Stratford MR, Dennis MF, Rojas AM.
    Radiother Oncol; 1997 Nov 01; 45(2):159-66. PubMed ID: 9424007
    [Abstract] [Full Text] [Related]

  • 35. ARCON: a novel biology-based approach in radiotherapy.
    Kaanders JH, Bussink J, van der Kogel AJ.
    Lancet Oncol; 2002 Dec 01; 3(12):728-37. PubMed ID: 12473514
    [Abstract] [Full Text] [Related]

  • 36. Concurrent carbogen and radiation therapy in children with high-risk brainstem gliomas.
    Aquino-Parsons C, Hukin J, Green A.
    Pediatr Blood Cancer; 2008 Feb 01; 50(2):397-9. PubMed ID: 17009221
    [Abstract] [Full Text] [Related]

  • 37. Effects of hyperbaric oxygen and normobaric carbogen on the radiation response of the rat rhabdomyosarcoma R1H.
    Hartmann KA, van der Kleij AJ, Carl UM, Hulshof MC, Willers R, Sminia P.
    Int J Radiat Oncol Biol Phys; 2001 Nov 15; 51(4):1037-44. PubMed ID: 11704328
    [Abstract] [Full Text] [Related]

  • 38. ARCON: accelerated radiotherapy with carbogen and nicotinamide in head and neck squamous cell carcinomas. The experience of the Co-operative group of radiotherapy of the european organization for research and treatment of cancer (EORTC).
    Bernier J, Denekamp J, Rojas A, Minatel E, Horiot J, Hamers H, Antognoni P, Dahl O, Richaud P, van Glabbeke M, Piérart M.
    Radiother Oncol; 2000 May 15; 55(2):111-9. PubMed ID: 10799722
    [Abstract] [Full Text] [Related]

  • 39. Carbogen and nicotinamide combined with unconventional radiotherapy in glioblastoma multiforme: a new modality treatment.
    Fatigante L, Ducci F, Cartei F, Colosimo S, Marini C, Prediletto R, Danesi R, Laddaga M, Del Tacca M, Caciagli P.
    Int J Radiat Oncol Biol Phys; 1997 Feb 01; 37(3):499-504. PubMed ID: 9112444
    [Abstract] [Full Text] [Related]

  • 40. Preliminary results of RTOG phase I/II study of misonidazole and radiation for bladder cancer.
    Mohiuddin M, Kramer S, Phillips T, Soberon M, Forgione H.
    Am J Clin Oncol; 1982 Oct 01; 5(5):551-4. PubMed ID: 7180834
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.